Short-term borrowings decreased 100.0%
Short-term borrowings changed -100.0% from the comparable as-filed period.
$299.5M→$00 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →DLTR financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue increased 7.0%
Revenue changed +7.0% from the comparable as-filed period.
$4.6B→$4.9B2 prior comparisons
Noncurrent long-term debt increased 20.7%
Noncurrent long-term debt changed +20.7% from the comparable as-filed period.
$2.4B→$2.9B3 prior comparisons
Working capital / assets moved 220 bp higher
Working capital / assets changed +220 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
0.95%→3.15%3 prior comparisons
Stock-based compensation increased 36.1%
Stock-based compensation changed +36.1% from the comparable as-filed period.
$14.4M→$19.6M3 prior comparisons
Total assets increased 4.8%
Total assets changed +4.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$13.4B→$14.0B3 prior comparisons
Capex / revenue moved 33 bp lower
Capex / revenue changed -33 basis points from the comparable as-filed period.
5.37%→5.04%2 prior comparisons
Selling, general & administrative increased 5.6%
Selling, general & administrative changed +5.6% from the comparable as-filed period.
$1.4B→$1.4B2 prior comparisons
Current liabilities decreased 5.3%
Current liabilities changed -5.3% from the comparable as-filed period.
$3.5B→$3.3B3 prior comparisons
Current ratio increased 9.4%
Current ratio changed +9.4% from the comparable as-filed period.
1.04→1.133 prior comparisons
SBC / revenue moved 9 bp higher
SBC / revenue changed +9 basis points from the comparable as-filed period.
0.32%→0.40%2 prior comparisons
Current assets increased 3.6%
Current assets changed +3.6% from the comparable as-filed period.
$3.6B→$3.7B3 prior comparisons
Capital expenditure increased 0.5%
Capital expenditure changed +0.5% from the comparable as-filed period.
$245.1M→$246.3M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.